Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Interest ReceivablesChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Change in Receivables: 2024-2025

  • Abivax's Change in Receivables fell 0.52% to $5.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $7.1 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2024, which is 132.04% up from last year.
  • Latest data reveals that Abivax reported Change in Receivables of $5.0 million as of Q2 2025, which was up 321.50% from -$2.3 million recorded in Q1 2025.
  • In the past 5 years, Abivax's Change in Receivables registered a high of $5.1 million during Q2 2024, and its lowest value of -$2.3 million during Q1 2025.
  • Over the past 2 years, Abivax's median Change in Receivables value was $2.1 million (recorded in 2024), while the average stood at $1.8 million.
  • Data for Abivax's Change in Receivables shows a maximum YoY plummeted of 209.07% (in 2025) over the last 5 years.
  • Over the past 2 years, Abivax's Change in Receivables (Quarterly) stood at $5.1 million in 2024, then fell by 0.52% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q2 2025, -$2.3 million for Q1 2025, and $5.1 million during Q2 2024.